Subscribe to Newsletter

Business Practice

Manufacture Contract Manufacturing Services

Ready for Anything

| Rob Coker

The Alliance for RTU has been founded to accelerate and improve manufacturing quality, consistency, and regulatory efficiency.

Manufacture Small Molecules

Pharma Needs a Dramatic Overhaul

Why the traditional model of drug development is no longer fit for purpose.

Manufacture Contract Manufacturing Services

Building Culture, Driving Growth

| 5 min read

Sitting Down With… Lars Petersen, President and CEO, FUJIFILM Diosynth Biotechnologies

Business & Regulation Business Practice

Driving the Future of Biopharma

| Rob Coker

Biopharma companies procrastinating on sustainability measures risk falling behind, according to Cytiva’ Global Biopharma Sustainability Review.

Manufacture Technology and Equipment

The Nonprofit Model for Manufacturing

| Stephanie Vine | 13 min read

Civica Rx is approaching generic drug manufacturing using a nonprofit model – and it’s working. We get the story behind their facility in Petersburg.

Business & Regulation Business Practice

Why Pharma Must Embrace AI and Open Source

| Brendan Frey | 4 min read

With open minds and open sources, the future is foundational – and bright.

Discovery & Development Formulation

Navigating the Challenges and Complexities of ADC Development

| Erika Kovacs | 5 min read

ADC development is a complex process that can be streamlined – and optimized – by taking the right partnerships and strategies into consideration.

Manufacture Small Molecules

How to Optimize Your API

| Richard Castledine | 4 min read

Tips to identify a safe, cost-efficient, and sustainable route to scalable API synthesis

Discovery & Development Clinical Trials

For Faster Trials, Improve Feasibility

| Christine Senn | 6 min read

The burden on clinical trials designers and healthcare professionals can only be eased by fixing a broken process: trial feasibility.

Business & Regulation Business Practice

Counterfeit Medicines: Getting On The Right Track

| 5 min read

Counterfeit deterrents are not yet available in some regions. We speak with Advanco CEO Alf Goebel to find out why.


Latest White Papers

Performance validation of ScatterX78 against NIST reference materials

| Contributed by Malvern Panalytical

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register